204 related articles for article (PubMed ID: 12043098)
1. [With alpha blockers, finasteride and nettle root against benign prostatic hyperplasia. Which patients are helped by conservative therapy?].
Vahlensieck W
MMW Fortschr Med; 2002 Apr; 144(16):33-6. PubMed ID: 12043098
[TBL] [Abstract][Full Text] [Related]
2. [Status of phytotherapeutic drugs in treatment of benign prostatic hyperplasia].
Dreikorn K; Schönhöfer PS
Urologe A; 1995 Mar; 34(2):119-29. PubMed ID: 7538709
[TBL] [Abstract][Full Text] [Related]
3. The impact of 5-alpha-reductase inhibitors on the number of prostatectomies for benign prostatic hyperplasia.
Agha AH; Roy JB; Culkin DJ; Lyon K
Adv Ther; 1995; 12(6):361-6. PubMed ID: 10163332
[TBL] [Abstract][Full Text] [Related]
4. [Benign prostatic hyperplasia: medical therapy].
Schlenker B; Gratzke C; Weidlich P; Seitz M; Reich O; Stief CG
MMW Fortschr Med; 2007 Aug; 149(33-34):29-31; quiz 32. PubMed ID: 17912863
[TBL] [Abstract][Full Text] [Related]
5. A review of the clinical efficacy and safety of 5alpha-reductase inhibitors for the enlarged prostate.
Naslund MJ; Miner M
Clin Ther; 2007 Jan; 29(1):17-25. PubMed ID: 17379044
[TBL] [Abstract][Full Text] [Related]
6. A comprehensive review on the stinging nettle effect and efficacy profiles. Part II: urticae radix.
Chrubasik JE; Roufogalis BD; Wagner H; Chrubasik S
Phytomedicine; 2007 Aug; 14(7-8):568-79. PubMed ID: 17509841
[TBL] [Abstract][Full Text] [Related]
7. [Drug therapy of benign prostatic hyperplasia].
Vahlensieck W; Fabricius PG; Hell U
Fortschr Med; 1996 Nov; 114(31):407-11. PubMed ID: 9036092
[TBL] [Abstract][Full Text] [Related]
8. Efficacy of terazosin and finasteride in symptomatic benign prostatic hyperplasia: A comparative study.
Anwarul Islam AK; Kashem MA; Shameem IA; Kibria SA
Bangladesh Med Res Counc Bull; 2005 Aug; 31(2):54-61. PubMed ID: 16967810
[TBL] [Abstract][Full Text] [Related]
9. [Conservative treatment of benign prostatic hyperplasia].
Romics I
Orv Hetil; 2008 Oct; 149(40):1875-80. PubMed ID: 18815106
[TBL] [Abstract][Full Text] [Related]
10. New use for alpha blockers: benign prostatic hyperplasia.
Hill SJ; Lawrence SL; Lepor H
Am Fam Physician; 1994 Jun; 49(8):1885-8, 1893-4. PubMed ID: 7515555
[TBL] [Abstract][Full Text] [Related]
11. Prostate cancer risk among users of finasteride and alpha-blockers - a population based case-control study.
Murtola TJ; Tammela TL; Määttänen L; Hakama M; Auvinen A
Eur J Cancer; 2007 Mar; 43(4):775-81. PubMed ID: 17251005
[TBL] [Abstract][Full Text] [Related]
12. Benign prostatic hyperplasia (BPH).
Harv Mens Health Watch; 2006 Aug; 11(1):3. PubMed ID: 17111474
[No Abstract] [Full Text] [Related]
13. [Results of the effectiveness of long-term treatment of patients with benign prostatic hyperplasia].
Tkachuk VN; Al'-Shukri SKh; Luk'ianov AE
Urologiia; 2002; (2):11-3. PubMed ID: 12077812
[TBL] [Abstract][Full Text] [Related]
14. The role of combination medical therapy in benign prostatic hyperplasia.
Greco KA; McVary KT
Int J Impot Res; 2008 Dec; 20 Suppl 3():S33-43. PubMed ID: 19002123
[TBL] [Abstract][Full Text] [Related]
15. What do we know about phytotherapy of benign prostatic hyperplasia?
Allkanjari O; Vitalone A
Life Sci; 2015 Apr; 126():42-56. PubMed ID: 25703069
[TBL] [Abstract][Full Text] [Related]
16. The impact of medical therapy on surgery for benign prostatic hyperplasia: a study comparing changes in a decade (1992-2002).
Vela-Navarrete R; Gonzalez-Enguita C; Garcia-Cardoso JV; Manzarbeitia F; Sarasa-Corral JL; Granizo JJ
BJU Int; 2005 Nov; 96(7):1045-8. PubMed ID: 16225526
[TBL] [Abstract][Full Text] [Related]
17. Single-blind, randomized controlled study of the clinical and urodynamic effects of an alpha-blocker (naftopidil) and phytotherapy (eviprostat) in the treatment of benign prostatic hyperplasia.
Yamanishi T; Yasuda K; Kamai T; Tsujii T; Sakakibara R; Uchiyama T; Yoshida K
Int J Urol; 2004 Jul; 11(7):501-9. PubMed ID: 15242359
[TBL] [Abstract][Full Text] [Related]
18. [Drugs against symptomatic, benign prostatic hyperplasia].
Johansen TE
Tidsskr Nor Laegeforen; 2002 Oct; 122(26):2544-5. PubMed ID: 12522881
[No Abstract] [Full Text] [Related]
19. FPIN's clinical inquiries. Medical treatment of benign prostatic hyperplasia.
Rich KT; Safranek S
Am Fam Physician; 2008 Mar; 77(5):665-6. PubMed ID: 18350766
[No Abstract] [Full Text] [Related]
20. An economic evaluation of doxazosin, finasteride and combination therapy in the treatment of benign prostatic hyperplasia.
McDonald H; Hux M; Brisson M; Bernard L; Nickel JC
Can J Urol; 2004 Aug; 11(4):2327-40. PubMed ID: 15380054
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
